Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Addus HomeCare Corporation (ADUS:NASDAQ), powered by AI.
Addus HomeCare Corporation is currently trading at $94.71. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Addus HomeCare Corporation on Alpha Lenz.
View Addus HomeCare Corporation's valuation metrics on Alpha Lenz.
“Addus HomeCare Corporation's ROE is 9.3%. Explore profitability and growth together.”
Ask for details →Addus HomeCare Corporation is a leading provider of comprehensive home care and support services, primarily focusing on helping seniors and individuals with chronic conditions maintain a high quality of life in their homes. The company specializes in personal care services, which include assistance with daily living activities such as bathing, grooming, and meal preparation. Addus HomeCare operates in multiple states across the U.S., delivering its services through a network of caregivers who are trained to offer personalized care plans tailored to each client's unique needs. In the financial market, Addus HomeCare Corporation serves as a significant player in the healthcare sector, addressing the growing demand for home-based care solutions as the population ages. The company's operations are crucial in the community-based care industry, working with Medicaid programs, managed care organizations, and other payers to provide cost-effective care alternatives. Founded in 1979 and headquartered in Frisco, Texas, Addus HomeCare continues to expand its footprint through strategic acquisitions and organic growth, cementing its role as a trusted provider in the evolving healthcare landscape.
“Addus HomeCare Corporation's ROE is 9.3%. Explore profitability and growth together.”
Ask for details →Addus HomeCare Corporation (ticker: ADUS) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 6,165 employees.
The current price is $94.71 with a P/E ratio of -x and P/B of -x.
ROE is 9.33% and operating margin is 9.74%. Annual revenue is $1.4B.